[How to diagnose and treat peritoneal infections in patients with terminal chronic renal insufficiency treated by peritoneal dialysis]
- PMID: 7700422
[How to diagnose and treat peritoneal infections in patients with terminal chronic renal insufficiency treated by peritoneal dialysis]
Abstract
There have been improvements in the technique of peritoneal dialysis (PD) over the last ten years. However, peritoneal infections remain the major complication associated with this treatment, and the risk of infection cannot be accurately predicted. Nevertheless, it is widely accepted that simple connections should be replaced by improved systems of connection, and that patient training is important. Peritoneal infection should be suspected when the dialysate is turbid, whether or not associated with peritoneal irritation. None of the various techniques used for the culture of dialysates has been shown to be either more sensitive or more specific than any of the others. Thus, collaboration between the physicians supervising the dialysis and microbiologists is necessary to choose the culture techniques best adapted. The sensitivity should be at least 85 to 90%. If the sensitivity is lower, the techniques used should be reconsidered. There have been several hundred publications assessing treatments of peritoneal infections associated with PD. However, no particular antibiotic treatment has been demonstrated to be systematically superior. The use of associated antibiotics seems to be preferable initially, until the causative agent has been identified. For example, vancomycin with a third generation cephalosporin seems to be the association of choice, because of its efficacy, tolerance and ease of use. The optimal duration of treatment has not been established by randomised study, but 10 days is commonly used for Gram-positive infections, and longer for Gram-negative. Whatever the treatment used, the success rate should be at least 80 to 90%. Randomised trials with sufficiently large numbers of patients are required to determine the indications and delay before withdrawal of the DP catheter in cases of peritonitis which do not respond to antibiotics.
Similar articles
-
Treatment of peritoneal dialysis-associated peritonitis with continuous versus intermittent vancomycin/teicoplanin and ceftazidime in children: preliminary results of a prospective randomized trial. Members of APN Arbeitsgemeinschaft Paidiatrische Nephrologie.Adv Perit Dial. 1995;11:296-301. Adv Perit Dial. 1995. PMID: 8534728 Clinical Trial.
-
[Prophylaxis and management of catheter-associated infections in peritoneal dialysis patients: recent studies and guidelines].Wien Klin Wochenschr. 2005;117 Suppl 6:73-82. doi: 10.1007/s00508-005-0488-7. Wien Klin Wochenschr. 2005. PMID: 16437337 German.
-
Use of bolus intraperitoneal aminoglycosides for treating peritonitis in end-stage renal disease patients receiving continuous ambulatory peritoneal dialysis and continuous cycling peritoneal dialysis.Adv Perit Dial. 2000;16:280-4. Adv Perit Dial. 2000. PMID: 11045311 Clinical Trial.
-
Antibiotic use in neonatal sepsis.Turk J Pediatr. 1998 Jan-Mar;40(1):17-33. Turk J Pediatr. 1998. PMID: 9722468 Review.
-
Encapsulating peritoneal sclerosis.Nephrology (Carlton). 2005 Jun;10(3):249-55. doi: 10.1111/j.1440-1797.2005.00413.x. Nephrology (Carlton). 2005. PMID: 15958037 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical